Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Arrivent Biopharma Inc (AVBP)

Arrivent Biopharma Inc (AVBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Arrivent Biopharma Inc 18 CAMPUS BLVD. SUITE 100 NEWTOWN SQUARE PA 19073 USA

www.arrivent.com Employees: 77 P: 628-277-4836

Sector:

Medical

Description:

ArriVent BioPharma Inc. is a clinical-stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. ArriVent BioPharma Inc. is based in NEWTOWN SQUARE, Pa.

Key Statistics

Overview:

Market Capitalization, $K 947,249
Enterprise Value, $K 901,709
Shares Outstanding, K 44,202
Float, K 35,989
% Float 81.42%
Short Interest, K 7,004
Short Float 15.85%
Days to Cover 25.09
Short Volume Ratio 0.82
% of Insider Shareholders 18.58%
% of Institutional Shareholders 9.48%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -166,310 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -35,540 K
EBIT, $ -177,530 K
EBITDA, $ -180,560 K

Growth:

1-Year Return 15.40%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.78 on 03/05/26
Next Earnings Date 05/11/26
Earnings Per Share ttm -4.41
EPS Growth vs. Prev Qtr 6.02%
EPS Growth vs. Prev Year -30.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

AVBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -62.48%
Return-on-Assets % -58.11%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.93
Book Value/Share 7.44
Interest Coverage -5.88
60-Month Beta 0.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.